mephenytoin has been researched along with Idiopathic Parkinson Disease in 1 studies
Mephenytoin: An anticonvulsant effective in tonic-clonic epilepsy (EPILEPSY, TONIC-CLONIC). It may cause blood dyscrasias.
mephenytoin : An imidazolidine-2,4-dione (hydantoin) in which the imidazolidine nucleus carries a methyl group at N-3 and has ethyl and phenyl substituents at C-5. An anticonvulsant, it is no longer available in the USA or the UK but is still studied largely because of its interesting hydroxylation polymorphism.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudjonsson, O | 1 |
| Sanz, E | 1 |
| Alván, G | 1 |
| Aquilonius, SM | 1 |
| Reviriego, J | 1 |
1 other study available for mephenytoin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Poor hydroxylator phenotypes of debrisoquine and S-mephenytoin are not over-represented in a group of patients with Parkinson's disease.
Topics: Aged; Debrisoquin; Female; Humans; Hydroxylation; Male; Mephenytoin; Middle Aged; Parkinson Disease; | 1990 |